2018 R&D Day: Building Tomorrow’s Breakthroughs



Molecular Partners is hosting its 2nd R&D update on “Building Tomorrow’s Breakthroughs”. This event is intended for institutional investors, sell-side analysts, investment bankers, and business development professionals.


Thursday, December 6, 2018
Check-In & Lunch                           11:30am – 12:00pm ET
Presentations and Q&A                 12:00pm – 2:30pm ET


The Yale Club
50 Vanderbilt Avenue
New York, NY 10017

Discussion topics will include:

  • Development strategy for MP0250 in multiple myeloma and
    update on clinical trials in NSCLC and multiple myeloma
  • Advancement of immuno-oncology pipeline
  • Research strategy and new research programs of the company
  • Latest clinical data on Allergan-licensed abicipar

RSVP below if you plan to attend, as space is limited:

Susan A. Noonan
S.A. Noonan Communications, LLC
+1 212 966-3650

Webcast information:

For those who are unable to attend in person, a live webcast and replay will be accessible on the company’s website, along with the accompanying presentation slides.